Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
CVKD: Cadrenal Therapeutics, Inc. Common Stock Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
CVKD
The Story
CVKD
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-670.4%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
2.68×
Cadrenal Therapeutics, Inc. Common Stock
CVKD
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Cadrenal Therapeutics, Inc. Common Stock
CVKD
NASDAQ
·
USD
·
Closed
$2.01
−3.83%
$2.01
−$0.08 (3.83%)
52W Range
1th
pctl
Volume
0.15×
avg
Mkt Cap
6.23M
USD
P/E
-0.4
TTM
Div Yield
–
ann
52W Range
1th
pctl
Volume
0.15×
avg
Market Cap
6.23M
USD
P/E Ratio
-0.4
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings